Related Experiment Video
Updated: Jan 22, 2026

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
Polydatin Attenuates Neuronal Loss via Reducing Neuroinflammation and Oxidative Stress in Rat MCAO Models
Fawad Ali Shah1,2, Lina Al Kury3, Tao Li4
1State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School, Peking University, Shenzhen, China.
Abstract:
Ischemic stroke is characterized by permanent or transient obstruction of blood flow, which initiates a cascading pathological process, starting from acute ATP loss and ionic imbalance to subsequent membrane depolarization, glutamate excitotoxicity, and calcium overload. These initial events are followed by neuroinflammation and oxidative stress, eventually causing neuronal neurosis and apoptosis. Complicated interplays exist between these steps happening across various stages, which not only represent the complicated nature of ischemic pathology but also warrant a detailed delineation of the underlying molecular mechanisms to develop better therapeutic options. In the present study, we examined the neuroprotective effects of polydatin against ischemic brain injury using a rat model of permanent middle cerebral artery occlusion (MCAO). Our results demonstrated that polydatin treatment reduced the infarction volume and mitigated the neurobehavioral deficits, sequentially rescued neuronal apoptosis. Ischemic stroke induced an elevation of neuroinflammation and reactive oxygen species, which could be attenuated by polydatin via the reduced activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase. In addition, polydatin upregulated the endogenous antioxidant nuclear factor erythroid 2-related factor 2, heme oxygenase-1, the thioredoxin pathway, and eventually reversed ischemic-stroke-induced elevation of ROS and inflammation in ischemic cortical tissue. The diverse and broad actions of polydatin suggested that it could be a multiple targeting neuroprotective agent in ameliorating the detrimental effects of MCAO, such as neuroinflammation, oxidative stress, and neuronal apoptosis. As repetitive clinical trials of neuroprotectants targeting a single step of stroke pathological process have failed previously, our results suggested that a neuroprotective strategy of acting at different stages may be more advantageous to intervene in the vicious cycles in MCAO.
Insights
Polydatin offers neuroprotection against ischemic stroke by reducing brain injury, inflammation, and neuronal death. This natural compound targets multiple pathways, suggesting a promising multi-action therapeutic strategy for stroke recovery.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Ischemic stroke involves complex pathological cascades including excitotoxicity, neuroinflammation, and oxidative stress.
- Current neuroprotective therapies targeting single pathways have shown limited clinical success.
- Understanding the molecular mechanisms of ischemic brain injury is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the neuroprotective effects of polydatin against ischemic brain injury.
- To elucidate the molecular mechanisms underlying polydatin's action in a rat model of middle cerebral artery occlusion (MCAO).
Main Methods:
- A rat model of permanent middle cerebral artery occlusion (MCAA) was used to induce ischemic stroke.
- Polydatin treatment was administered to assess its impact on infarction volume and neurobehavioral deficits.
- Key molecular markers of neuroinflammation, oxidative stress, and apoptosis were analyzed.
Main Results:
- Polydatin significantly reduced infarction volume and improved neurobehavioral outcomes in MCAO rats.
- Treatment with polydatin attenuated neuroinflammation and oxidative stress by inhibiting p38 MAPK and JNK pathways.
- Polydatin upregulated endogenous antioxidant systems, including Nrf2, HO-1, and the thioredoxin pathway, reversing ROS and inflammation.
Conclusions:
- Polydatin exhibits broad-spectrum neuroprotective properties against ischemic stroke.
- Its multi-targeting mechanism, addressing neuroinflammation, oxidative stress, and apoptosis, makes it a promising therapeutic agent.
- A multi-stage intervention strategy, as exemplified by polydatin, may overcome the limitations of single-target therapies in stroke treatment.
Related Concept Videos
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Adaptations that Reduce Water Loss
Redox Titration: Other Oxidizing and Reducing Agents
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Oxidation-Reduction Reactions
Oxidation Numbers

